Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
A commentary in response to the recent Cochrane review of clinical trial data on different anti-amyloid treatments, that states these medicines show ‘no clinically meaningful benefit’ for people with Alzheimer’s.
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
In May 2026, two blood tests have received a Conformité Européenne (CE) mark for within the European Economic Area (EEA), including Elecsys® pTau217, developed by Roche in collaboration with Eli Lilly, as well as the Lumipulse G pTau 217 Plasma assay by Fujirebio Europe N.V.
The 37th Global Conference of Alzheimer’s Disease International (ADI 2026) brought together a truly global collective in Lyon, uniting over 1,500 delegates from more than 90 countries. With 1,133 abstracts submitted and 672 posters presented, the conference showcased the breadth of innovation, research and collaboration shaping the future of dementia…
In April, there has been a plethora of activity around dementia and brain health policy, as governments, regional bodies, and civil society strengthen collaboration to address one of the region’s fastest-growing public health challenges.
In February, ADI CEO Paola Barbarino and Head of Membership Laura Aubert visited Morocco for a series of high-level stakeholder and member meetings aimed at expediting progress towards addressing dementia in the country.
Argentina has officially launched its first National Dementia Plan, a major milestone for the country and the Americas region, following years of persistent advocacy.
Alzheimer’s Disease International announces a new branded content feature, Threads of Hope, to be produced for ADI by BBC StoryWorks Commercial Productions.
As we approach the end of the calendar year, ADI CEO Paola Barbarino shares her end-of-year message with our members, friends and colleagues, reflecting on our work in 2025 and offering a preview of what 2026 will bring.
9 December, ADI CEO Paola Barbarino joined the 19th Rencontre France Alzheimer, hosted by France Alzheimer in Paris. This event convened representatives from across the country, as well as and Francophone countries, to discuss the latest developments in dementia treatment, diagnostics, care and support.